PDB9 Budget IMPACT Analysis of Empagliflozin in Type-2 Diabetes Patients with High Cardiovascular Risk in South Korea Based on Empa-REG OUTCOME® Trial: HIRA(HEALTH INSURANCE REVIEW ASSESSMENT SERVICE)-NPS (NATIONAL PATIENTS SAMPLE) Databas ...
Abstract
Authors
M. Kim T. Kim J. Gordon L. Varghese B. Kim